Skip To Main Content
Fabienne Kinzelmann on Muck Rack

Fabienne Kinzelmann

Verified
Zurich, Zürich
As seen in: Bloomberg News, MSN, MSN Philippines, UOL, The Economic Times, Yahoo News, Der Spiegel, Die Welt, Los Angeles Times, Yahoo Finance, Yahoo Finance Australia and
Reporter @Bloomberg | Burns Fellow '21 | ✊🏻EQV ✊🏻@QuaJou | prev. @Handelszeitung @Blickch @derspiegel @faznet & co-founder @tonic_magazin
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fabienne

Contact Fabienne, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Warum Nestlé nun in NBA-Basketball macht: Fünf Themen des Tages

|
By Fabienne Kinzelmann Verified, Dyfed Loesche, Stephan Kahl Verified
| Yahoo Finance Deutschland Verified
(Bloomberg) -- Fabienne Kinzelmann über einen Marketing-Kurswechsel — Abonnieren Sie unseren Newsletter Fünf Themen des Tages und erhalten Sie samstags das Hauptstadtgeflüster direkt in Ihre Mailbox. Folgen Sie uns auch auf unserer LinkedIn-Seite.
Open in Who Shared Issue with article?

Bayer plans $2.2 billion Ohio drug plant against tariff backdrop

|
By Fabienne Kinzelmann Verified, Sonja Wind Verified
| Crain's Cleveland Business Verified
Bayer AG plans to invest $2.2 billion in a new manufacturing site in Ohio, the latest in a series of investment pledges by European pharmaceutical companies that have been under pressure from the Trump administration to push down drug prices and boost US manufacturing. Get unlimited access to trusted industry news — anytime, on any device.
Open in Who Shared Issue with article?

Bayer Plans $2.2 Billion US Drug Plant Against Tariff Backdrop

|
By Fabienne Kinzelmann Verified, Sonja Wind Verified
| Bloomberg Tax Verified
plans to invest $2.2 billion in a new manufacturing site in Ohio, the latest in a series of investment pledges by European pharmaceutical companies that have been under pressure from the Trump administration to push down drug prices and boost US manufacturing. The new factory will make medicines for cancer, cardiovascular and kidney diseases, the German conglomerate said Friday. The site in New Albany is expected to create about 600 jobs, with production starting in 2031.
Open in Who Shared View Duplicates (2) Issue with article?
See all 1,339 licensed articles (1,347 Total)